/PRNewswire/ Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons.
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
– First-of-its-kind authorization provides potential marketing differentiation and opportunities for largest testing category –
– Testament to Invitae s product and lab quality –
– Sets.
Certain kinds of tumors can be inherited within families. Identifying the underlying genetic cause is important in treatment, but most studies on these tumors have been carried out on Caucasian populations.